ARK Genomic Revolution ETF Rating $22.66 -0.95 (-4.00%) Closing price 05/2/2025 03:59 PM EasternExtended Trading$22.64 -0.02 (-0.09%) As of 05/2/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHeadlinesHoldingsOwnershipRatingsBuy This Stock ARK Genomic Revolution ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.ARKG Aggregate RatingModerate Buy 2.73Holdings in ARKG have an aggregate rating of Moderate Buy based on 398 analyst ratings issued in the past year covering 32 companies (99.8% of the portfolio).ARKG Aggregate Price Target$22.67High Prediction$22.67Average Prediction$22.67Low Prediction$22.67Holdings in ARKG have an aggregate price target of $22.67 and a range of $22.67 to $22.67 covering 32 companies (99.8% of the portfolio).ARKG Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy12 Buy rating(s)Moderate Buy14 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by ARK Genomic Revolution ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 33 ARKG Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings9.03%TWSTTwist Bioscience$39.24+4.1%3.6456 of 5 stars2.70$52.80 34.6%10Upcoming EarningsNews CoveragePositive News8.23%CRSPCRISPR Therapeutics$38.25+1.4%3.0315 of 5 stars2.48$73.11 91.1%21Upcoming EarningsPositive News6.98%RXRXRecursion Pharmaceuticals$5.70+3.6%2.2769 of 5 stars2.33$8.20 43.9%6Upcoming EarningsGap Up6.97%TEMTempus AI$57.06+10.0%1.6057 of 5 stars2.54$61.08 7.1%13Upcoming EarningsGap UpHigh Trading Volume6.53%GHGuardant Health$46.85-4.1%4.4719 of 5 stars3.05$51.64 10.2%22Earnings ReportAnalyst ForecastNews CoveragePositive NewsGap UpHigh Trading Volume6.27%NTRANatera$156.66+3.5%2.9018 of 5 stars3.00$175.76 12.2%16Upcoming EarningsInsider TradePositive News5.94%ADPTAdaptive Biotechnologies$9.84+33.7%3.084 of 5 stars3.00$9.60 -2.4%5Earnings ReportAnalyst ForecastNews CoveragePositive NewsGap UpHigh Trading Volume5.92%SDGRSchrödinger$25.29+1.6%2.5096 of 5 stars3.00$32.80 29.7%6Upcoming EarningsPositive NewsGap Up4.38%CDNACareDx$15.00-0.5%3.679 of 5 stars2.57$30.33 102.2%7Earnings ReportInsider TradePositive NewsGap Up4.04%VCYTVeracyte$30.35+2.2%4.0058 of 5 stars2.70$42.60 40.4%10Upcoming EarningsShort Interest ↑Positive NewsHigh Trading Volume3.53%BEAMBeam Therapeutics$20.24+2.1%3.1326 of 5 stars3.00$49.45 144.3%14Upcoming EarningsShort Interest ↑News Coverage3.32%ABSIAbsci$3.031.7692 of 5 stars3.00$8.40 177.2%5Positive News2.91%IONSIonis Pharmaceuticals$32.78+3.4%4.4027 of 5 stars2.65$56.67 72.9%20Earnings ReportAnalyst ForecastInsider TradeNews CoveragePositive News2.48%TXG10x Genomics$8.43+4.1%4.679 of 5 stars2.38$18.85 123.6%16Upcoming EarningsNews CoveragePositive NewsGap Up2.42%PSNLPersonalis$4.16+7.8%3.6586 of 5 stars3.00$7.80 87.5%5Upcoming EarningsNews Coverage2.18%NTLAIntellia Therapeutics$8.84+2.3%4.6741 of 5 stars2.65$36.68 315.0%20Upcoming Earnings2.12%ARCTArcturus Therapeutics$12.83+2.6%3.0115 of 5 stars3.13$59.20 361.4%8Upcoming EarningsNews CoveragePositive News1.71%AMGNAmgen$281.22-0.9%4.0982 of 5 stars2.41$308.18 9.6%22Earnings ReportAnalyst ForecastPositive NewsGap Up1.69%BFLYButterfly Network$2.32-0.9%2.5583 of 5 stars3.00$3.00 29.3%2Earnings ReportInsider TradeNews CoverageGap Down1.60%NRIXNurix Therapeutics$11.27+1.0%1.9794 of 5 stars2.84$30.44 170.1%19Analyst ForecastNews Coverage1.45%PACBPacific Biosciences of California$1.13+1.8%3.0726 of 5 stars2.50$2.45 116.8%10Upcoming EarningsNews CoveragePositive News1.35%MASS908 Devices$5.60+4.5%1.1334 of 5 stars2.50$5.33 -4.8%41.31%VRTXVertex Pharmaceuticals$501.15+0.5%3.9744 of 5 stars2.64$514.91 2.7%25Upcoming EarningsPositive News1.23%VEEVVeeva Systems$236.63+2.0%3.6968 of 5 stars2.52$254.92 7.7%25Positive News1.16%ILMNIllumina$77.88+1.8%4.7181 of 5 stars2.48$137.55 76.6%21Upcoming EarningsAnalyst ForecastNews CoveragePositive News1.04%QSIQuantum-Si$1.26+8.6%2.2908 of 5 stars2.67$3.48 175.8%3Upcoming Earnings1.01%CERSCerus$1.35+3.8%2.0824 of 5 stars3.00$3.50 159.3%2Earnings ReportNews Coverage0.99%INCYIncyte$62.53+0.8%4.7431 of 5 stars2.17$73.53 17.6%18Earnings ReportAnalyst ForecastAnalyst Revision0.77%REGNRegeneron Pharmaceuticals$605.61+2.6%4.8427 of 5 stars2.88$892.60 47.4%26Earnings ReportDividend AnnouncementAnalyst ForecastAnalyst RevisionHigh Trading Volume0.55%CMPSCOMPASS Pathways$4.19+2.2%2.4566 of 5 stars3.00$20.20 382.1%6Upcoming EarningsNews CoveragePositive News0.40%LABStandard BioTools$1.20+8.1%3.1117 of 5 stars2.50$2.50 108.3%2Upcoming EarningsNews Coverage0.32%PRMEPrime Medicine$1.68-3.4%2.4605 of 5 stars3.11$13.38 696.1%90.00%RPTXRepare Therapeutics$1.43+1.4%3.3703 of 5 stars2.50$4.50 214.7%4Upcoming EarningsNews Coverage This page (BATS:ARKG) was last updated on 5/3/2025 by MarketBeat.com Staff From Our PartnersGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredThe collapse has already startedThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredMassive red flag about American consumerWhy is the U.S. Dollar suddenly crashing? Pundits on either side of the aisle have been warning that the U....Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ARK Genomic Revolution ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share ARK Genomic Revolution ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ARKG Stock Free ARKG Stock Alerts